Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
105
Views
14
CrossRef citations to date
0
Altmetric
Original Research

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder

Gang Wang1 Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
,
Alexander McIntyre2 Department of Psychiatry, Penticton Regional Hospital, Penticton, BC, Canada
,
Willie R Earley3 AstraZeneca Pharmaceuticals, Wilmington, DE, USA
,
Shane R Raines3 AstraZeneca Pharmaceuticals, Wilmington, DE, USA
&
Hans Eriksson4 AstraZeneca R&D, Södertälje, Sweden
Pages 201-216 | Published online: 30 Jan 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Barbara B Barton, Felix Segger, Kai Fischer, Michael Obermeier & Richard Musil. (2020) Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis. Expert Opinion on Drug Safety 19:3, pages 295-314.
Read now
Richard Musil, Michael Obermeier, Paul Russ & Michael Hamerle. (2015) Weight gain and antipsychotics: a drug safety review. Expert Opinion on Drug Safety 14:1, pages 73-96.
Read now

Articles from other publishers (12)

Che-Yin Lin, Cheng-Hen Chiang, Mei-Chih Meg Tseng, Ka-Wai Tam & El-Wui Loh. (2023) Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials. European Neuropsychopharmacology 67, pages 22-36.
Crossref
Akira Nishi, Kyosuke Sawada, Hiroyuki Uchida, Masaru Mimura & Hiroyoshi Takeuchi. (2022) Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis. Pharmacopsychiatry 56:01, pages 5-17.
Crossref
Tao Chen, Wenming Zhao, Yu Zhang, Jiakuai Yu, Ting Wang, Jiajia Zhang, Yifei Li, Jiajia Zhu & Dao-min Zhu. (2022) Neural mechanism of the relationship between sleep efficiency and clinical improvement in major depressive disorder: A longitudinal functional magnetic resonance imaging study. Frontiers in Psychiatry 13.
Crossref
Aurélie Delacrétaz, Anaïs Glatard, Céline Dubath, Mehdi Gholam, Franziska Gamma, Armin Gunten, Philippe Conus & Chin B. Eap. (2021) Valproate is associated with early decrease of high‐density lipoprotein cholesterol levels in the psychiatric population. Basic & Clinical Pharmacology & Toxicology 129:1, pages 26-35.
Crossref
E.W. Miller, D.S. Shoup, M.W. Recktenwald & E.W. Recktenwald. (2020) Nefarious nausea: A systematic review and meta-analysis of the risks of nausea in the treatment of major depressive, obsessive-compulsive, and anxiety disorders with selective serotonin re-uptake inhibitors (SSRIs). Journal of Affective Disorders Reports 1, pages 100016.
Crossref
Evyn M. Peters, Rudy Bowen & Lloyd Balbuena. (2020) Melancholic depression and response to quetiapine: A pooled analysis of four randomized placebo-controlled trials. Journal of Affective Disorders 276, pages 696-698.
Crossref
Lorenzo Guizzaro, David Dickinson Vaughan Morgan, Andrea Falco & Ciro Gallo. (2020) Hamilton scale and MADRS are interchangeable in meta-analyses but can disagree at trial level. Journal of Clinical Epidemiology 124, pages 106-117.
Crossref
Janus Christian Jakobsen, Kiran Kumar Katakam, Anne Schou, Signe Gade Hellmuth, Sandra Elkjær Stallknecht, Katja Leth-Møller, Maria Iversen, Marianne Bjørnø Banke, Iggiannguaq Juhl Petersen, Sarah Louise Klingenberg, Jesper Krogh, Sebastian Elgaard Ebert, Anne Timm, Jane Lindschou & Christian Gluud. (2017) Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 17:1.
Crossref
Vatsalya Vatsalya, Akash Pandey, Melanie L. Schwandt, Matthew C. Cave, Shirish S. Barve, Vijay A. Ramchandani & Craig J. McClain. (2016) Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients. Clinical Drug Investigation 36:11, pages 935-944.
Crossref
Mark Zimmerman, Matthew Multach, Emily Walsh, Lia K. Rosenstein, Douglas Gazarian & Heather L. Clark. (2016) Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. CNS Drugs 30:3, pages 185-191.
Crossref
Sheng-Min WangChangsu HanSoo-Jung LeeTae-Youn JunAshwin A PatkarPrakash S MasandChi-Un Pae. (2016) Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update. Chonnam Medical Journal 52:3, pages 159.
Crossref
Roger S. McIntyre, Philip Gorwood, Michael E. Thase, Charlie Liss, Dhaval Desai, Ji Chen & Michael Bauer. (2015) Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder. Journal of Clinical Psychopharmacology 35:6, pages 706-710.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.